Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOptiBiotix Health Regulatory News (OPTI)

Share Price Information for OptiBiotix Health (OPTI)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 18.25
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 1.50 (8.571%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 18.25
OPTI Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

SlimBiome® Approved by Health Canada

25 Oct 2021 07:00

RNS Number : 0118Q
OptiBiotix Health PLC
25 October 2021
 

OptiBiotix Health plc

("OptiBiotix" or the "Company" or the "Group")

 

SlimBiome® Approved by Health Canada

 

OptiBiotix Health plc (AIM: OPTI), a life sciences business developing compounds that modulate the microbiome to tackle metabolic syndrome, systemic low grade inflammation, obesity and diabetes, cardiovascular disease and high cholesterol, announces that SlimBiome® has received approval for use as a licensed product for weight management by Health Canada, a Canadian federal institution responsible for helping Canadians maintain and improve their health.

 

In Canada, every supplement must be approved and authorised by Health Canada, as a licensed Natural Health Product (NHP) and receive a National Product Number (NPN). The NPN is displayed on the product label and is confirmation that a product has been assessed and found to be safe and effective with approved health claims. As part of the approval process Health Canada have validated the scientific and clinical data on SlimBiome® and determined the following health and nutrition claims can be made: -

 

· Helps to lower cholesterol levels by reducing cholesterol absorption from the gastrointestinal tract

· Helps to maintain normal blood glucose levels and supports a healthy glucose metabolism

· Helps to prevent chromium deficiency and maintains the body's ability to metabolize nutrients

· Complementary to a healthy lifestyle with a calorie-reduced diet and regular physical activity for individuals involved in weight management

· Helps to support a feeling of fullness

· Is a source of fiber and prebiotics

 

Health Canada is seen as one of the world's leading authorities on regulating functional ingredients and supplements ensuring products are safe and marketed with approved health and nutrition claims. Health Canada approval is internationally recognised as a mark of a product quality, safety, and effectiveness and can lead to shortened product registration procedures in other international markets.

 

SlimBiome® is a patented weight management ingredient supported by independent human clinical studies (Keleszade et al, 2020) which show it reduces hunger, cravings for sweet and savoury foods, and fat intake. In addition to clinical studies, independent consumer surveys have shown that customers who used SlimBiome® in combination with a calorie restricted diet lose on average 2-3lbs (1-1.5kg) per week, experience a relief from feeling hungry and have fewer cravings for food, leading to easier and more sustainable dieting.

 

SlimBiome® has achieved three major industry awards: European Weight Management Ingredient of the Year (NutraIngredients 2018), Asia Weight Management Ingredient of the Year (NutraIngredients 2019), and most recently, best weight management product in the USA (Nutrition Industry Executive Award 2021).

 

René Kamminga, CEO of OptiBiotix Limited, commented: "We are pleased to achieve product approval for SlimBiome® by one of the toughest regulatory bodies in the world. This is a significant achievement and brings further international recognition to SlimBiome® as a scientifically backed and proven weight management ingredient. It underlines the value of the investment we made in a number of human clinical studies showing SlimBiome's® effectiveness and the creation of a large IP portfolio. SlimBiome® has won three major industry awards across all regions, obtained CE marked medical device registration in Europe, and now is a weight management product with approved health and nutrition claims by Health Canada. This opens up the Canadian and North American market for new sales opportunities and provides further validation of our product in international markets."

 

Carla Fabian, Sales Director of Agropur (Optibiotix's partner in North America) commented: "Health Canada approval and recognition with an NPN number is exciting news as this allows Agropur to safely manufacture, distribute, and sell SlimBiome in the Canadian marketplace. The registration is recognised by consumers, brand owners, retailers, and professional health care workers like pharmacists and dietitians. Everyone can be assured that SlimBiome® is safe, of high quality, and can amongst others help deliver benefits with respect to cholesterol reduction, maintaining blood glucose levels and compliment a healthy lifestyle. We, along with Optibiotix, look forward to partnering with brand owners who are looking to add proven science-based weight management functionality to existing products or to assist with new product development utilising our extensive innovation resources."

 

This announcement contains information which, prior to its disclosure, was considered inside information for the purposes of the UK Market Abuse Regulation and the Directors of the Company are responsible for the release of this announcement.

 

For further information, please contact:

 

OptiBiotix Health plc

www.optibiotix.com

Stephen O'Hara, Chief Executive

Contact via Walbrook below

 

 

 

 

Cairn Financial Advisers LLP (NOMAD)

Tel: 020 7213 0880

Liam Murray / Jo Turner / Ludovico Lazzaretti

Cenkos Securities plc (Broker)

Tel: 020 7397 8900

Callum Davidson / Neil McDonald

 

Michael Johnson / Russell Kerr (Sales)

 

 

 

Walbrook PR Ltd

Mob: 07876 741 001

Anna Dunphy

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
REAFLFIRITLFFIL
Date   Source Headline
18th Nov 20207:00 amRNSLicense and supply agreement with Genuine Health
12th Oct 20207:00 amRNSLaunch of weight management products
9th Oct 20202:00 pmRNSInvestor presentation
8th Oct 20207:00 amRNSHead of Quality & Operations appointment
6th Oct 20207:00 amRNSExclusive distribution agreement
5th Oct 202011:05 amRNSSecond Price Monitoring Extn
5th Oct 202011:00 amRNSPrice Monitoring Extension
2nd Oct 202011:00 amRNSPrice Monitoring Extension
2nd Oct 20207:00 amRNSFDA Investigational New Drug authorisation
28th Sep 20207:00 amRNSExclusive distribution agreement
24th Sep 20207:00 amRNSHalf-year Report
22nd Sep 20207:00 amRNSLicense agreement for SlimBiome® Medical in the US
17th Sep 20207:00 amRNSDistributor agreement with Ayalla Marketing
15th Sep 202011:06 amRNSSecond Price Monitoring Extn
15th Sep 202011:00 amRNSPrice Monitoring Extension
15th Sep 20207:00 amRNSSweetBiotix sweet fibres agreement
3rd Sep 20202:05 pmRNSSecond Price Monitoring Extn
3rd Sep 20202:00 pmRNSPrice Monitoring Extension
3rd Sep 202011:05 amRNSSecond Price Monitoring Extn
3rd Sep 202011:00 amRNSPrice Monitoring Extension
11th Aug 20207:00 amRNSScientific and commercial development update
5th Aug 20207:00 amRNSExtension of terms for OptiBiome with OptiPharm
30th Jul 20207:00 amRNSExtension of terms for WellBiome with Maxum Foods
23rd Jul 20207:00 amRNSExtension of terms for WellBiome with Agropur
20th Jul 20207:00 amRNSTrading and commercial update
16th Jul 20207:00 amRNSExtension of terms, territories and products
14th Jul 20207:00 amRNSExtension of terms for WellBiome
9th Jul 202011:29 amRNSResult of AGM
6th Jul 20207:00 amRNSExtension of terms for WellBiome
1st Jul 20207:00 amRNSDistribution agreement with Actial Farmaceutica
29th Jun 20207:00 amRNSLaunch of WellBiome
17th Jun 20207:00 amRNSNotice of AGM
3rd Jun 20207:00 amRNSExercise of Warrant
2nd Jun 20203:35 pmRNSGrant of Options
1st Jun 20203:45 pmRNSHolding(s) in Company
1st Jun 20207:00 amRNSCambridge Commodities appointment as distributor
28th May 20207:00 amRNSFinal Results
20th May 20207:00 amRNSLaunch of SlimBiome gummies in USA
18th May 20207:00 amRNSTrading and commercial update
11th May 20207:00 amRNSExclusive distribution agreement with MAXCARE Inc
5th May 20207:00 amRNSDistribution of products in China and Hong Kong
4th May 20207:00 amRNSNon-exclusive agreement with Smart For Life
17th Apr 20204:24 pmRNSHolding(s) in Company
17th Apr 202011:03 amRNSPlacing and Related Party Transaction
6th Apr 20207:00 amRNSSlimBiome® contract manufacturing agreement
2nd Apr 20207:00 amRNSSlimBiome® contract manufacturing agreement
31st Mar 20207:00 amRNSExclusive licence agreement for OptiBiome®
24th Mar 20207:00 amRNSExtension of territories for GoFigure®
23rd Mar 20207:00 amRNSChange of accounting year end
19th Mar 20204:42 pmRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.